简体中文

Press releases

06 Feb 2023

JIXING Announces Acquisition of an Innovative Cardiovascular Asset for Global Development

Read article
16 Dec 2022

JIXING Announces the Appointment of Sandy Mou as Chief Executive Officer

Read article
07 Nov 2022

JIXING Announces NMPA Acceptance of New Drug Application Submission for Omecamtiv Mecarbil

Read article
17 Oct 2022

Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia

Read article
07 Sep 2022

JIXING Announces the Grand Opening of the New Headquarter Office in China

Read article
26 Aug 2022

JIXING Announces the First Patient Enrolled in China Cohort of Phase 3 Clinical Trial of Aficamten

Read article
Load more

Developing innovative cardiometabolic therapies globally

Copyright © 2026 CORXEL. All Rights Reserved.
Designed & built by SampsonMay

沪ICP备20017872号-3

沪公网安备31010602008424号